Neuren Pharmaceuticals Limited (ASX:NEU)

Neuren Pharmaceuticals Revenue

Neuren Pharmaceuticals had revenue of 28.28M AUD in the half year ending June 30, 2025, a decrease of -55.06%. This brings the company's revenue in the last twelve months to 218.86M, up 12.09% year-over-year. In the year 2024, Neuren Pharmaceuticals had annual revenue of 216.83M, down -6.51%.

• Revenue (ttm): 218.86M
• Revenue Growth: +12.09%
• P/S Ratio: 7.64
• Revenue / Employee: 27.36M
• Employees: 8
• Market Cap: 1.67B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	216.83M	-15.11M	-6.51%
Dec 31, 2023	231.94M	216.53M	1,404.46%
Dec 31, 2022	15.42M	12.22M	382.23%
Dec 31, 2021	3.20M	2.48M	345.89%
Dec 31, 2020	717.00K	222.00K	44.85%